Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201309086 Principal Investigator: Wagner-Johnston, Nina
Title: A Phase I Open-Label, Multi-Dose, Dose Escalation Study of PRT06270 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) or B-Cell Non Hodgkin Lymphoma (NHL)
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The primary purpose of this research study is to see whether PRT062070 (the study drug) is safe for use in patients with CLL, SLL, or B-cell NHL and to determine the best dose to use for future studies.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)